search
Documents
USP Propranolol Hydrochloride Assay by HPLC-UV (TN-1090)
The introduction of a new C8 phase to the Kinetex core-shell technology family allows for the ultra-high efficiency, speed and throughput benefits to be applied to methods requiring the use of a C8 (USP L7) column. The application of this technology to the USP assay for propranolol hydrochloride is shown to reduce analysis time while meeting the system suitability requirements for this USP monograph.
USP Propranolol Hydrochloride Assay by HPLC-UV (TN-1090)
The introduction of a new C8 phase to the Kinetex core-shell technology family allows for the ultra-high efficiency, speed and throughput benefits to be applied to methods requiring the use of a C8 (USP L7) column. The application of this technology to the USP assay for propranolol hydrochloride is shown to reduce analysis time while meeting the system suitability requirements for this USP monograph.
Document Type:
Technical Notes
Target Industries:
Techniques:
Brands:
Separation Modes:
Reversed Phase
Can't view? Disable your browser's pop-up blocker.
USP Propranolol Hydrochloride Assay by HPLC-UV (TN-1090)
The introduction of a new C8 phase to the Kinetex core-shell technology family allows for the ultra-high efficiency, speed and throughput benefits to be applied to methods requiring the use of a C8 (USP L7) column. The application of this technology to the USP assay for propranolol hydrochloride is shown to reduce analysis time while meeting the system suitability requirements for this USP monograph.
| Target Industries: | Pharmaceutical |
| Techniques: | HPLC |
| Brands: | Kinetex |
| Separation Modes: | Reversed Phase |
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide